SIRT2 and Alzheimer disease: Another study found that early inhibition of SIRT2 prevents excessive neuroinflammation by decreasing the levels of IL-1β, IL-6, GFAP, and TNF-α, which suggests that SIRT2 is an emerging target for improving excessive neuroinflammation or AD progression (Diaz-Perdigon et al., 2020).